Dose Ranging Study of SPL7013 Gel for Treatment of Bacterial Vaginosis (BV)

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine the efficacy of SPL7013 Gel in the treatment of bacterial vaginosis.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Starpharma Pty Ltd

Criteria

Inclusion Criteria:

• Women aged 18-45 years with a diagnosis of BV according to Amsel's criteria and a Nugent score of ≥4

• Otherwise healthy

Exclusion Criteria:

• No active STIs